Navigation Links
GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg)

in pain management, along with ingenuity, Adolor is seeking to make a positive difference for patients, caregivers and the medical community. For more information, visit www.adolor.com.

About GlaxoSmithKline

GlaxoSmithKline is one of the world's leading research-based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit GlaxoSmithKline on the World Wide Web at www.gsk.com.

Adolor Forward-Looking Statements

This release, and oral statements made with respect to information contained in this release, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those which express plan, anticipation, intent, contingency, goals, targets or future development and/or otherwise are not statements of historical fact. These statements are based upon management's current expectations and are subject to risks and uncertainties, known and unknown, which could cause actual results and developments to differ materially from those expressed or implied in such statements. Such known risks and uncertainties relate to, among other factors: the risk that the OBD development program remains on hold indefinitely; the risk that Adolor may not receive regulatory approval of Entereg (R) (alvimopan) for POI, OBD, or any other indication; the risk that Adolor may not be able to adequately address the deficiencies in the November 2006 FDA approvable letter; the risk that a risk management plan could materially adversely affect the commercial prospects for Entereg, if regulatory approval is achieved; the risk that Adolor may not obtain FDA approval for Entereg in POI, whether due to Adolor's inability to provide additional data satisfactory to the FDA to obtain approval for the NDA, the adequacy of the safety and efficacy data from all of the
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:12/24/2014)... -- ResMed (NYSE: RMD ) today announced its ... device manufacturer BMC Medical Co., Ltd. The ... below infringe ResMed,s patents, and entered an order prohibiting BMC ... the United States : , iVolve nasal ... nasal pillows mask , iVolve full face mask ...
(Date:12/24/2014)...   Assurex Health, a personalized medicine company ... for behavioral health and chronic pain conditions, today ... equity financing from new and existing investors, according ... Chief Executive Officer. The financing will ... Health,s GeneSight ®  products.  GeneSight,s patented ...
(Date:12/24/2014)... 2014 Tianyin Pharmaceutical Co., Inc. (NYSE ... patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded ... that the Company achieved the Public Notice (Gong ... certificate of TPI,s Qionglai Facility (QLF) from the ... notice period is a significant procedure of GMP ...
Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
... BLUE BELL, Pa., Feb. 24, 2011 Inovio Pharmaceuticals, Inc. ... development of therapeutic and preventive vaccines against cancers and infectious ... CEO will present a company overview at the Cowen & ... at the Boston Marriott Copley Place in Boston, MA. ...
... 2011 Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) ... the Citi 2011 Global Health Care Conference in New York ...  Bruce Cozadd, the company,s chairman and chief executive officer, will ... the presentation may be accessed from the Investors section of ...
Cached Medicine Technology:Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference 2Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference 3
(Date:12/25/2014)... (PRWEB) December 26, 2014 ... BambooFlooringChina.com combines beauty, strength and durability. Today, the ... promotion, which is valid until Jan. 30, 2015. ... grain of traditional hardwood. BambooFlooringChina.com is a well-known ... help consumers worldwide to find a reliable bamboo ...
(Date:12/25/2014)... three months the trends for evening dresses shift ... one of the hottest styles in the next few months.” ... releases 26 A-line sweetheart evening dresses, and announces the availability ... are trying our best to help a lady to show ... affordable prices, we provide discounted delivery costs to our customers ...
(Date:12/25/2014)... Recently, BellasDress has launched its Christmas Sale, ... has chosen their best-selling lace wedding dresses, vintage bridesmaid ... season. , Now, BellasDress.com features popular women’s dresses, ... discount prices. The business hopes everyone can have a ... , “All our elegant products are made with exquisite ...
(Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide professional shopping ... of the models at LunaDress.co.uk come with big discounts, up to ... veil can turn out to be a most exciting memory and ... always bring surprise to a wedding. On the updated fashion blog, ... veils for a big day . , Going out with friends ...
(Date:12/25/2014)... 2014 (HealthDay News) -- Among early stage breast cancer ... half of one percent will eventually develop leukemia as ... The finding comes from a review of more ... 2007, and it suggests that the risk for developing ... had previously thought. "The frequency of bone marrow ...
Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... Reporter , MONDAY, March 28 (HealthDay News) -- Radiation ... airline passengers is not a significant health threat, University ... since the U.S. Transportation Safety Administration (TSA) installed full-body ... 486 scanners in 78 U.S. airports, and it plans ...
... Amanda Gardner HealthDay Reporter , MONDAY, March 28 ... traditional exposure therapy may help anxious patients overcome their fear ... exposing people to the thing they fear -- be it ... But while promising, this experimental treatment is not ...
... surgery should be considered earlier in the treatment of ... can result from diabetes, according to an International Diabetes ... the 2nd World Congress on Interventional Therapies for Type ... written by 20 leading experts in diabetes and bariatric ...
... water they pass through and also affect the distribution carbon-dioxide-absorbing ... researchers from UC San Diego and the University of San ... the growth of phytoplankton in the Atlantic sector of the ... Alley" east of the Antarctic Peninsula. Enhanced phytoplankton growth ...
... News) -- Seeing other people scratching can cause your ... The team at Wake Forest Baptist Medical Center investigated ... "It is conceivable that the neuronal networks or mechanisms ... involved in contagious yawning, a phenomenon that is still ...
... the differences in heart disease among women and men ... as gender and ethnicity matter when it comes to ... Transgender People: Building a Foundation for Understanding, a new ... ensure that clinical researchers identify and address the needs ...
Cached Medicine News:Health News:Airport Scanners Appear Safe, Study Finds 2Health News:Airport Scanners Appear Safe, Study Finds 3Health News:Airport Scanners Appear Safe, Study Finds 4Health News:Stress Hormone Might Help Overcome Fear of Heights 2Health News:International Diabetes Federation supports surgery to treat diabetes 2Health News:International Diabetes Federation supports surgery to treat diabetes 3Health News:Icebergs in the Antarctic play important role in carbon cycle 2Health News:Seeing Others Scratch Can Trigger Your Own Itch 2
... I system is a unique ... combines dual width capability with ... roll" design. Specifically developed to ... patients, the easy-to-use Tri-Flex I ...
... offer a wide selection of solutions for ... use. The sterile water for inhalation and ... plastic pour bottles in 500 and 1000mL ... nebulizer kits or can be used alone ...
... FIO 2 500ML 0.9% Sodium Chloride ... provide unmatched performance and ease of use. You ... from 28% to 100% FIO 2 . We ... for inhalation, USP; 0.45% sodium chloride inhalation, USP; ...
... NEBULIZER EMPTY W/AIR ENT 35%-100% FIO2, ... adjustable from 35% to 100%. It has ... immersion-type heater., ,Empty Nebulizers 5007P and ... to 98%. , ,Convenient slip-on heaters ...
Medicine Products: